[The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]. / La pentoxifylline, un épargneur de corticoïdes dans le traitement de la sarcoïdose : à propos d'une observation.
Rev Pneumol Clin
; 74(1): 48-51, 2018 Feb.
Article
em Fr
| MEDLINE
| ID: mdl-29122398
ABSTRACT
INTRODUCTION:
The pentoxifylline seems to have some effects on immune cells by inhibiting tumor necrosis factor alpha (TNFα). Its role as a sparing corticosteroids in the treatment of sarcoidosis remains to be defined. CLINICAL CASE We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine. It was finally improved clinically, functionally and by a thoracic computed tomography with addition of pentoxifylline.CONCLUSION:
When the tolerance of the pentoxifylline is good and there is not a bleeding risk, the benefit-risk in the long term might be interesting in some patients with sarcoidosis corticodependent.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pentoxifilina
/
Inibidores de Fosfodiesterase
/
Sarcoidose
/
Fator de Necrose Tumoral alfa
/
Glucocorticoides
Limite:
Female
/
Humans
/
Middle aged
Idioma:
Fr
Ano de publicação:
2018
Tipo de documento:
Article